We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Addressing Key Challenges in Cell and Gene Therapy Manufacturing
Industry Insight

Technology Networks spoke with Hugh H. Tansey, senior director of innovation and growth programs for laboratory equipment at Thermo Fisher Scientific to learn more about how the CTS Series Laboratory Equipment can deliver solutions for the key challenges in cell and gene therapy manufacturing.

Read More

Leading the Charge in the Cryo-EM Resolution Revolution
Industry Insight

See how cryo-EM advances are changing scientific research, particularly in cell and drug discovery studies, and the role that precision instruments are playing in this.

Read More

Advanced Cell Screening and Imaging Reveals How the Cardiac System Responds in Drug Development
Industry Insight

In drug discovery, time and monetary investments increase significantly the further candidates advance through the preclinical phase of testing, analysis and evaluation. By excluding non-viable compounds for safety and toxicity reasons early on, resources can be redirected to bring the most promising drugs to market sooner.

Read More

Pushing the Boundaries of Translational Molecular Imaging
Industry Insight

Professor Ron Heeren recently embarked on a study to bring together the spatial molecular information that is provided by MALDI-MSI with the microproteomic characterization generated by LC-MS on the same tissue specimen, on a single instrument. Heeren and colleagues were successful in this feat. Their work is published in the journal Proteomics and forms the basis of this interview.

Read More

Engineering Innovative CAR T-Cell Therapy Candidates for Cancer
Industry Insight

Technology Networks recently had the pleasure of speaking with Celyad Oncology’s CEO Filippo Petti. In this interview, Petti discusses key immunotherapy advances, highlights the two main CAR T-cell therapy approaches and elaborates on the company’s “off-the-shelf” CAR T cells.

Read More

Can You Achieve Rapid MS Analysis With No Sample Prep?
Industry Insight

News of how innovations can assist scientists and their workflows is not uncommon, but claims of “industry revolutions”, however, tend to be a little less frequent. The Echo® MS System from SCIEX is touted as being one such revolution, we spoke to Neil Walsh to learn more.

Read More

A Smarter Way To Remove Host Cell Protein Contamination From Gene Therapies
Industry Insight

In this piece, Ejvind Mørtz and Todd Stawicki explain why it’s critical that gene therapy products are free of host cell proteins and how this can be ensured in the production process, so that these next-generation drugs can fulfil their potential as one-shot cures for a range of diseases, from rare genetic conditions to cancer.

Read More

A Conversation With Professor Josef Penninger on the Journey to a COVID-19 Therapeutic
Industry Insight

The ACE2 receptor has garnered significant attention for the wrong reasons over recent months. Could it point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist Professor Josef Penninger explains why he thinks so, and discusses the latest clinical data obtained from testing the soluble ACE2 receptor, APN01.

Read More

Using Organoids in the Study of Infectious Diseases
Industry Insight

By providing greater physiologic relevance and a species- or patient-specific test platform, organoids overcome many limitations of conventional 2D cultures and even live-animal disease models.

Read More

Tapping Into Information Locked in Our T Cells To Fight COVID-19
Industry Insight

T cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.

Read More

 
Advertisement